Vivoryon Therapeutics N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 12 okt 2015 - 08:19

Statutaire naam Vivoryon Therapeutics N.V.

Titel Probiodrug collaborates with the Paul-Flechsig-Institute for Brain Research, Leipzig University, Germany

Bericht Probiodrug collaborates with the Paul-Flechsig-Institute for Brain Research, Leipzig University, Germany HALLE/SAALE, Germany, 12 October 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), announced that it has entered into a Collaborative Research and Material Transfer Agreement with Prof Steffen Rossner of the Paul-Flechsig-Institute for Brain Research, Leipzig University, Germany.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201510120000000006_Probiodrug_12102015.pdf (opens in a new window)

Datum laatste update: 31 december 2025